TickerFactsScreenerDevelopers

ATOSSA THERAPEUTICS, INC. (ATOS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $02010: $10.3K2011: $1.91M2012: $1.73M2013: $6.34M2014: $8.50M2015: $3.72M2016: $3.03M2017: $7.22M2018: $10.38M2019: $12.58M2020: $39.55M2021: $136.38M2022: $110.89M2023: $88.46M2024: $71.08M2025: $41.30M$41.30M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$41.30M-41.9%
2024$71.08M-19.6%
2023$88.46M-20.2%
2022$110.89M-18.7%
2021$136.38M+244.8%
2020$39.55M+214.4%
2019$12.58M+21.2%
2018$10.38M+43.8%
2017$7.22M+138.4%
2016$3.03M-18.5%
2015$3.72M-56.3%
2014$8.50M+34.0%
2013$6.34M+267.6%
2012$1.73M-9.7%
2011$1.91M+18536.7%
2010$10.3K—
2009$0—